Alexion Pharmaceuticals Inc 's Revenue in the fiscal year 2020 $ 6,069.90 millions
Alexion Pharmaceuticals Inc 's Revenue in the fiscal year 2019 $ 4,991.10 millions
Alexion Pharmaceuticals Inc 's Revenue in the fiscal year 2018 $ 4,131.20 millions
Alexion Pharmaceuticals Inc 's Revenue in the fiscal year 2017 $ 3,551.10 millions
Alexion Pharmaceuticals Inc 's Revenue in the fiscal year 2016 $ 3,084.00 millions
ALXN Revenue first quarter 2021 Y/Y Growth Comment
Alexion Pharmaceuticals Inc reported Revenue increase of 13.27% year on year in the first quarter 2021, to $ 1,636.50 millions, this is lower than Alexion Pharmaceuticals Inc 's recent average Revenue improvement of 24.99%.
Looking into first quarter 2021 results within Major Pharmaceutical Preparations industry 118 other companies have achieved higher Revenue growth. While Alexion Pharmaceuticals Inc ' s Revenue growth of 13.27% ranks overall at the positon no. 1743 in the first quarter 2021.
ALXN Revenue ( Y/Y Growth %)
2021
2020
2019
2018
4th Quarter
December
-
14.99 %
22.63 %
24.08 %
3rd Quarter
September
-
25.78 %
23.05 %
19.5 %
2nd Quarter
June
-
20.05 %
15.15 %
14.58 %
1st Quarter
March
13.27 %
26.69 %
22.51 %
7 %
FY
-
21.61 %
20.81 %
-
Financial Statements
Alexion Pharmaceuticals Inc 's first quarter 2021 Revenue
Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021
Alexion Pharmaceuticals Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
95.19 %
6.81 %
-46.12 %
(Dec 31 2015)
ALXN's I. Quarter Q/Q Revenue Comment
Alexion Pharmaceuticals Inc achieved in the I. Quarter 2021 below company average Revenue growth of 2.81% quarter on quarter, to $ 1,636.50 millions.
Within Major Pharmaceutical Preparations industry 80 other companies have achieved higher Revenue quarter on quarter growth. While Alexion Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 1624.
Alexion Pharmaceuticals Inc achieved in the I. Quarter 2021 below company average Revenue growth of 2.81% quarter on quarter, to $ 1,636.50 millions.
Within Major Pharmaceutical Preparations industry 80 other companies have achieved higher Revenue quarter on quarter growth. While Alexion Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 1624.
Alexion Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Mar 31 2021)
12 Months Ending (Dec 31 2020)
12 Months Ending (Sep 30 2020)
12 Months Ending (Jun 30 2020)
12 Months Ending (Mar 31 2020)
Cumulative Revenue 12 Months Ending
$ 6,261.60
$ 6,069.90
$ 5,862.40
$ 5,536.80
$ 5,295.50
Y / Y Revenue Growth (TTM)
18.24 %
21.61 %
23.79 %
23.07 %
22 %
Year on Year Revenue Growth Overall
Ranking
# 864
# 66
# 604
# 60
# 514
Seqeuential Revenue Change (TTM)
3.16 %
3.54 %
5.88 %
4.56 %
6.1 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1713
# 133
# 768
# 69
# 586
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2021 period, Alexion Pharmaceuticals Inc 's cumulative twelve months Revenue were $ 6,262 millions, company would post below average annual Revenue growth of 6.1% year on year, if the fiscal year would end at Mar 31 2021. A slow-down in the Alexion Pharmaceuticals Inc 's Revenue growth from the 1591.8% growth in Dec 31 2020.
In the Healthcare sector 199 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 66 to 864.
With the quarterly Revenue reported in the Mar 31 2021 period, Alexion Pharmaceuticals Inc 's cumulative twelve months Revenue were $ 6,262 millions, company would post below average annual Revenue growth of 9.74% year on year, if the fiscal year would end at Mar 31 2021. A slow-down in the Alexion Pharmaceuticals Inc 's Revenue growth from the 1591.8% growth in Dec 31 2020.
In the Healthcare sector 199 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 66 to 864.
About Alexion Pharmaceuticals Inc Revenue Growth Rates (ALXN), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
23.21%